Employer record no. 15231
Novo Nordisk Research Center Seattle Inc.
US DOL LCA disclosure data, FY2020 to FY2026
Total LCA filings
22
Certified
17
Denied
0
FY2025 filings
1
Filings by fiscal year
* partial fiscal year; quarters still being published by DOL
Peer rank
#1,302 of 2,686 healthcare employers by filings
The ledger
| Fiscal year | Filed | Certified | Denied | Avg offered wage | Avg prevailing |
|---|---|---|---|---|---|
| FY2020 | 4 | 4 | 0 | $88,000 | $76,284 |
| FY2023 | 6 | 6 | 0 | $137,417 | $115,766 |
| FY2024 | 7 | 7 | 0 | $159,086 | $122,533 |
| FY2025 | 1 | 0 | 0 | $172,500 | $157,643 |
| FY2026 * | 4 | 0 | 0 | $124,500 | $97,136 |
What they file for
- senior engineer i$166,3333
- associate director-business development$204,5002
- cell culture associate ii$80,0002
- cell culture technician$75,0462
- data scientist ii$119,8002
- engineer ii$81,4532
- senior engineer - r&d medical device$137,0002
- associate scientist$102,0001
Where
- lexington, ma9
- fremont, ca6
- seattle, wa4
- cambridge, ma2
- san francisco, ca1
Every number on this page is free. Members get an email when this employer files again, a CSV of the full record, and the complete rankings with state and job-title filters.
Watch this employerGet the quarterly H-1B update, free
When DOL publishes new filings we send what changed: the biggest movers and the slimmest wage premiums. No account needed. Members also get alerts for Novo Nordisk Research Center Seattle Inc. and any other employer they watch.
Certification rate 77.3%How these numbers are computed